3 verified Molecular Pharmacology specialists

Molecular Pharmacology Assignment Help & Online Tutoring

Molecular pharmacology is the branch of pharmacology that explains how drugs act at the level of molecules: how they bind receptors, ion channels, enzymes and transporters, and which signalling events follow inside the cell. FLN Tutors (Freelancer Network) gives one-to-one molecular pharmacology help to pharmacology, pharmacy, biomedical science and M.Pharm students, explaining receptor families, Kd and Bmax, Ki from IC50, agonists and antagonists, Schild analysis and G protein and kinase signalling step by step, with worked calculations on data like yours. Matched to a verified specialist who knows your course, your university's marking criteria, and your deadline.

100% ConfidentialFree RevisionsPlagiarism-Free
140+
Topics covered
3
Molecular Pharmacology specialists

Online Molecular Pharmacology tutoring

FLN offers one-to-one online Molecular Pharmacology tutoring with verified subject specialists. Sessions focus on core theory, clinical application and exam preparation, including Drug Receptors, Receptor Pharmacology, Signal Transduction and G Protein Coupled Receptors, using your own course material, so you understand the subject and can apply it yourself.

Last updated

Levels we tutor

  • Undergraduate
  • Master's
  • PhD

What is molecular pharmacology help?

It is one-to-one support from a pharmacology tutor who explains how drugs act at the level of receptors, channels, enzymes and signalling pathways, and helps with calculations, data analysis and essays. For whole-body drug effects, see pharmacology help; for absorption, distribution and elimination, see pharmacokinetics.

Most requests involve data: a saturation binding curve to fit, a competition assay to convert into a Ki, a shifted concentration–response curve to analyse, or a signalling pathway to draw for an essay. The tutor works a similar dataset with you, shows the equation behind each software output and explains what a marker expects in the results and discussion.

What you needBest optionWhat you get
Lessons through a receptor or cell signalling moduleLive one-to-one tutoringReceptor theory explained with curves drawn as you go
Binding, Schild or EC50 calculationsHomework helpFull working with units and assumptions stated
A practical report or data assignmentAssignment help and lab report helpFeedback on curve fitting, figures and discussion within your institution's rules

Get a free molecular pharmacology quote.

Molecular pharmacology at a glance: key facts

These are the definitions, equations and course facts that molecular pharmacology modules, practical reports and exams use most often. The content is educational only and is not prescribing or treatment guidance.

ItemKey fact
DefinitionThe study of drug action at the molecular level: binding to targets, the conformational change that follows, and the signalling it triggers
Main drug targetsReceptors (GPCRs, ligand-gated ion channels, kinase-linked and nuclear receptors), voltage-gated ion channels, enzymes and transporters
AffinityHow tightly a ligand binds, measured by the equilibrium dissociation constant Kd; a lower Kd means higher affinity
EfficacyThe ability of a bound ligand to activate the receptor; full agonists, partial agonists, antagonists and inverse agonists differ in efficacy, not necessarily in affinity
OccupancyFraction occupied = [L] ÷ ([L] + Kd), the Hill–Langmuir equation
Competition bindingKi = IC50 ÷ (1 + [L] ÷ Kd), the Cheng–Prusoff equation
Binding energyΔG° = RT ln Kd, so every tenfold change in Kd shifts ΔG° by about 5.9 kJ/mol at 37 °C
Typical course levelSecond- and third-year BSc pharmacology and biomedical science, MPharm and PharmD, M.Pharm and MSc research modules
Assessment typesData-handling exams, binding and organ-bath practical reports, mechanism essays and research proposals
SoftwareGraphPad Prism for curve fitting, receptor databases for ligand and target data

The British Pharmacological Society publishes curriculum and education resources that many UK pharmacology degrees use to set learning outcomes for receptor pharmacology.

Molecular pharmacology topic map: where students get stuck

Molecular pharmacology is where students first meet equations behind drug action, and most errors come from mixing up binding terms with response terms. The map shows each sticking point.

TopicWhere students get stuckHow a tutor helps
Receptor familiesGPCRs, ion channels, kinase-linked and nuclear receptorsFamily comparison tables
BindingSaturation and competition bindingWorked occupancy calculations
AgonismFull, partial and inverse agonistsCurve comparisons
AntagonismCompetitive and non-competitiveWorked Schild analysis
G protein signallingGs, Gi and Gq pathwaysPathway diagrams
Kinase signallingReceptor tyrosine kinases and JAK–STATPathway diagrams
RegulationDesensitisation and internalisationMechanism summaries
New conceptsBiased agonism and allosteric modulatorsExample tables

Molecular pharmacology topics we help with

Tutors cover molecular and receptor pharmacology syllabi.

AreaTopics
Receptor theoryOccupancy theory, efficacy, spare receptors, operational model
Binding assaysSaturation, competition, Kd, Ki, Bmax, Scatchard plots
GPCRsG proteins, second messengers, arrestins
Ion channelsLigand-gated and voltage-gated channels
Enzyme-linked and nuclear receptorsKinases, steroid and thyroid hormone receptors
RegulationDesensitisation, tolerance, receptor up- and downregulation
MethodsRadioligand binding, reporter assays, CRISPR, structural biology

How do drugs bind their targets, and what forces hold them there?

Before Kd, efficacy and signalling make sense, students need a clear picture of what binding is. Drug–target binding is a reversible chemical interaction for most drugs, driven by several weak forces acting together in a pocket that fits the drug's shape.

ForceWhat it isTypical role in binding
Ionic (electrostatic)Attraction between oppositely charged groups, such as a protonated amine and an aspartate residueStrong at short range; often the first contact that orients a ligand in an aminergic GPCR pocket
Hydrogen bondsSharing of a hydrogen between electronegative atoms such as O and NGive selectivity because they need precise distances and angles
Van der WaalsWeak attractions between atoms in close contactIndividually tiny, but add up across a well-fitting surface
Hydrophobic effectRelease of ordered water when non-polar surfaces meetOften the largest single contribution to affinity
Covalent bondsA shared-electron bond formed with the targetRare; produces irreversible inhibition, which behaves very differently in assays

From binding to action. Binding alone does nothing until the target changes shape. In a GPCR, an agonist stabilises an active conformation that couples to a G protein; an antagonist binds without favouring that state; an inverse agonist favours the inactive state and lowers constitutive activity. This is why affinity (Kd) and efficacy are separate quantities and must be discussed separately in essays.

Orthosteric and allosteric sites. Most textbook drugs bind the orthosteric site, the same pocket as the natural ligand. Allosteric modulators bind elsewhere and change how the natural ligand binds or signals, which is why they can produce effects that a simple competitive model cannot explain.

Kinetics as well as affinity. Kd is the ratio koff ÷ kon, so two ligands with the same Kd can have very different off-rates. The time a ligand stays bound, its residence time of 1 ÷ koff, is now a regular topic in final-year modules and drug discovery case studies.

Worked example: receptor occupancy and binding

A ligand binds a receptor with Kd = 2 nM and Bmax = 800 fmol/mg protein.

QuestionWorkingAnswer
Fractional occupancy at 6 nM[L] ÷ ([L] + Kd) = 6 ÷ 875%
Specific binding at 6 nM0.75 × 800600 fmol/mg
Concentration for 50% occupancyEqual to Kd2 nM
Concentration for 90% occupancy[L] = 9 × Kd18 nM

In real tissues, a full response may need far less than full occupancy when there are spare receptors.

Worked example: Schild analysis and pA2

A competitive antagonist shifts an agonist curve to the right. At 10 nM antagonist the EC50 rises from 5 nM to 55 nM.

StepWorkingResult
Dose ratio (DR)55 ÷ 511
Antagonist dissociation constantKB = [B] ÷ (DR − 1) = 10 ÷ 101 nM
pA2−log10(1 × 10⁻⁹)9.0
Schild plot checkSlope of log(DR − 1) against log[B]Close to 1 for simple competitive antagonism

Worked example: saturation binding and the Scatchard plot

In a saturation experiment, increasing concentrations of radioligand are added to membranes, with and without a large excess of unlabelled drug. Binding in the presence of excess drug is non-specific; specific binding = total − non-specific. Illustrative data for a receptor with Kd = 1.5 nM and Bmax = 1,200 fmol/mg, where non-specific binding rises by 50 fmol/mg per nM:

[L] free (nM)Specific binding B (fmol/mg)B ÷ [L] (fmol/mg per nM)
0.51,200 × 0.5 ÷ 2.0 = 300600
11,200 × 1 ÷ 2.5 = 480480
31,200 × 3 ÷ 4.5 = 800267
61,200 × 6 ÷ 7.5 = 960160
121,200 × 12 ÷ 13.5 = 1,06789

At 3 nM, for example, the measured total would be 950 fmol/mg and the non-specific 150, giving 800 specific.

Reading the Scatchard plot. Plotting B ÷ [L] against B gives a straight line for a single site: slope = −1 ÷ Kd, x-intercept = Bmax and y-intercept = Bmax ÷ Kd. Between the 1 and 3 nM points the slope is (267 − 480) ÷ (800 − 480) = −0.667 nM⁻¹, so Kd = 1.5 nM, and the y-intercept is 1,200 ÷ 1.5 = 800.

What to write about it. The Scatchard transformation distorts experimental error, because B appears on both axes. Fit the untransformed hyperbola B = Bmax[L] ÷ (Kd + [L]) by non-linear regression, as GraphPad Prism does, and use the Scatchard plot only to show the data or spot a second site (a curved line). Note that the top concentration should reach roughly ten times Kd to define Bmax: 90% occupancy needs 9 × 1.5 = 13.5 nM here, so the 12 nM point sits just short of it.

Worked example: converting an IC50 into a Ki (Cheng–Prusoff)

Competition binding measures how well an unlabelled drug displaces a fixed concentration of radioligand. The result is an IC50, but the IC50 depends on how much radioligand you used, so it cannot be compared between labs. The Cheng–Prusoff equation converts it to the inhibition constant Ki, which does not: Ki = IC50 ÷ (1 + [L] ÷ Kd).

QuantityValue
Radioligand concentration [L]1 nM
Radioligand Kd (from saturation binding)0.5 nM
Measured IC50 of the test drug60 nM
StepWorkingResult
[L] ÷ Kd1 ÷ 0.52
Ki60 ÷ (1 + 2)20 nM
pKi−log₁₀(20 × 10⁻⁹)7.70
IC50 expected with 0.1 nM radioligand20 × (1 + 0.1 ÷ 0.5)24 nM

The last row shows the point: the same drug, with the same Ki, gives an IC50 of 60 nM in one assay and 24 nM in another, purely because of the radioligand concentration.

Assumptions to state. The equation holds for competitive interaction at a single site at equilibrium, with ligand depletion negligible. A Hill slope of the competition curve well away from 1 suggests more than one site or a non-competitive mechanism, and the conversion should then be treated with caution. Report pKi values with their standard error, because the log values are close to normally distributed and the raw Ki values are not.

Worked example: Hill slope and the steepness of a concentration–response curve

The Hill equation describes a concentration–response curve: E = Emax × [A]ⁿ ÷ ([A]ⁿ + EC50ⁿ), where n is the Hill slope. Rearranged, the concentration giving p% of the maximum is ECp = EC50 × (p ÷ (100 − p))^(1/n).

Hill slope nEC20EC80EC80 ÷ EC20EC90 ÷ EC10
10.25 × EC504 × EC501681
20.5 × EC502 × EC5049

With n = 1, going from 10% to 90% of the response needs an 81-fold rise in concentration, close to two log units. With n = 2, a ninefold rise is enough, so the curve is much steeper.

Interpreting the slope. A slope of 1 is what simple one-site binding predicts. Steeper curves can arise from cooperativity, from signal amplification downstream of the receptor, or from a threshold in the tissue response. Shallower curves can mean several receptor subtypes or sites with different affinities. In a report, state the fitted slope with its confidence interval and say whether it differs from 1 before interpreting it; many curves in organ baths are fitted with the slope fixed at 1 when the data do not justify more.

Why EC50 is not Kd. For a full agonist in a tissue with spare receptors, the response saturates before the receptors do, so the EC50 can sit well below the Kd. That is the commonest confusion in this topic and the reason binding and functional data are measured separately.

Worked example: an insurmountable antagonist that lowers the maximum

A competitive antagonist shifts the agonist curve to the right with no change in the maximum, which is what Schild analysis uses. An insurmountable antagonist, binding irreversibly or at an allosteric site, instead depresses the maximum. When there is no receptor reserve, the remaining maximum is Emax(antagonist) ÷ Emax(control) = 1 ÷ (1 + [B] ÷ KB).

Question. 30 nM of a non-competitive antagonist reduces the maximum response to 25% of control. Find KB and predict the maximum at 10 nM.

StepWorkingResult
Set up1 ÷ (1 + 30 ÷ KB) = 0.251 + 30 ÷ KB = 4
Solve30 ÷ KB = 3KB = 10 nM
pKB−log₁₀(10 × 10⁻⁹)8.0
Maximum at 10 nM1 ÷ (1 + 10 ÷ 10)50% of control

What changes with spare receptors. If the tissue has a receptor reserve, a low concentration of an irreversible antagonist first shifts the curve to the right with no fall in the maximum, because the spare receptors make up the loss; only higher concentrations depress it. Furchgott used this behaviour with phenoxybenzamine to estimate agonist affinity. So a rightward shift alone does not prove competitive antagonism: check that the shift is surmountable at high agonist concentrations and that the Schild slope is close to 1.

FeatureCompetitive (surmountable)Non-competitive or irreversible
Effect on curveParallel rightward shiftMaximum falls, after any initial shift
Overcome by more agonist?YesNo
Measure of potencypA2 from Schild analysispKB from the fall in maximum

Worked example: binding energy, pKd and residence time for Drug X

This example links binding constants to thermodynamics and kinetics, a combination that appears in final-year and master's papers. Drug X and Drug Y are fictional ligands; the numbers are chosen for teaching. Practice maths for exams only. Not clinical guidance; always follow your local protocol and prescriber.

Part A: from Kd to binding free energy. Drug X binds its receptor with Kd = 2 nM (2 × 10⁻⁹ M) at 37 °C (310 K). Use ΔG° = RT ln Kd, with R = 8.314 J mol⁻¹ K⁻¹ and Kd expressed in mol/L relative to a 1 M standard state.

StepWorkingResult
RT8.314 × 3102,577 J/mol
ln Kdln(2 × 10⁻⁹)−20.03
ΔG°2,577 × (−20.03)about −51.6 kJ/mol
pKd−log₁₀(2 × 10⁻⁹)8.70

A ligand with a tenfold weaker Kd of 20 nM has ΔG° of about −45.7 kJ/mol. The difference, about 5.9 kJ/mol, equals RT ln 10, so every log unit of affinity is worth roughly 5.9 kJ/mol at body temperature. This is why a single extra hydrogen bond can change affinity by around tenfold.

Part B: from rate constants to residence time. Drug X has an association rate constant kon = 1 × 10⁷ M⁻¹ s⁻¹.

QuantityWorkingResult
koffKd × kon = (2 × 10⁻⁹) × (1 × 10⁷)0.02 s⁻¹
Dissociation half-lifeln 2 ÷ koff = 0.693 ÷ 0.02about 34.7 s
Residence time1 ÷ koff50 s

Drug Y has the same kon but a Kd of 0.2 nM, so koff = 0.002 s⁻¹ and its residence time is 500 s, about 8.3 minutes. In a washout experiment Drug Y keeps blocking the receptor long after Drug X has left, even though both follow the same simple binding model.

Where marks are lost. Using log₁₀ instead of the natural log in ΔG°, forgetting to convert nM to M, or quoting ΔG° as positive. State the standard state and temperature in one line and examiners accept the method.

How do you analyse a concentration–response experiment step by step?

Organ bath and cell-based assays produce the same kind of data, and practical reports are marked on the same sequence of steps.

  1. Express each response as a percentage of the maximum in that tissue or well, so preparations of different size can be pooled.
  2. Plot against log concentration, never linear concentration; the sigmoid shape and the EC50 only make sense on a log axis.
  3. Fit a four-parameter logistic curve (bottom, top, log EC50, Hill slope) to each preparation, then average pEC50 values, not EC50 values.
  4. Compare conditions statistically with the right test for paired or unpaired preparations, and report n as the number of animals or independent cultures, not wells.
  5. Interpret: a change in pEC50 is a change in potency; a change in the top is a change in maximum effect, which points to efficacy or insurmountable antagonism.
  6. State the limits: desensitisation during cumulative dosing, drug breakdown in the bath and time-dependent loss of tissue response.

A report that says "the antagonist shifted the curve" earns little; one that gives the pEC50 values with error, the dose ratio and what the parallel shift implies earns most of the marks.

Which signalling pathway does each receptor use?

Essay and exam questions expect you to name the receptor, its coupling and the second messenger in one line. These are the textbook examples most courses use.

ReceptorFamilyCoupling or mechanismMain messenger or effect
β₁- and β₂-adrenoceptorsGPCRGsAdenylyl cyclase on, cAMP up, protein kinase A
α₁-adrenoceptorGPCRGqPhospholipase C, IP₃ and DAG, Ca²⁺ release
α₂-adrenoceptorGPCRGi/ocAMP down
Muscarinic M₂GPCRGi/ocAMP down; K⁺ channels opened by Gβγ (slows the heart)
Muscarinic M₃GPCRGqCa²⁺ up (smooth muscle, glands)
μ-opioid receptorGPCRGi/ocAMP down, K⁺ channels open, Ca²⁺ channels close
Nicotinic acetylcholine receptorLigand-gated ion channelChannel opens in millisecondsNa⁺ entry, depolarisation
GABA-A receptorLigand-gated ion channelChannel opensCl⁻ entry, inhibition; benzodiazepines bind an allosteric site
Insulin receptorKinase-linked (receptor tyrosine kinase)AutophosphorylationIRS proteins, PI3K–Akt pathway
Glucocorticoid receptorNuclear receptorLigand–receptor complex enters the nucleusChanges gene transcription over hours

How to use the table in an answer.

  1. Name the receptor family and its time scale: ion channels act in milliseconds, GPCRs in seconds, kinase-linked receptors in minutes, nuclear receptors in hours.
  2. Name the G protein or mechanism.
  3. Name the effector enzyme or channel and the messenger.
  4. Finish with the cell response, such as smooth muscle contraction or a change in heart rate.

For drug-by-drug clinical uses and adverse effects, use the pharmacology page; this table is about mechanism only and is educational, not prescribing guidance.

Which laboratory methods does molecular pharmacology use?

Course descriptions for molecular pharmacology modules list methods as often as theory: cloning of drug targets, mutagenesis, expression systems, binding and functional assays and structure–activity relationships. Practical reports and research proposals are marked on whether you chose the right method for the question.

MethodWhat it tells youTypical exam or report point
Cloning and expression in cell lines (such as HEK293 or CHO cells)Lets one receptor subtype be studied in isolationExplain why a recombinant system avoids mixed receptor populations in native tissue
Site-directed mutagenesisWhich amino acids form the binding pocket or control activationA large loss of affinity after one mutation suggests that residue contacts the ligand
Radioligand and fluorescent binding assaysAffinity (Kd, Ki) and receptor number (Bmax)Separate total, non-specific and specific binding before fitting
Functional assays (cAMP, calcium, reporter genes, BRET and FRET)Potency (EC50) and efficacyCompare agonist potency only when efficacy is also reported
Electrophysiology (patch clamp)Ion channel opening, current size and gatingDistinguish channel block from a change in gating
Structural biology (X-ray crystallography and cryo-electron microscopy)The shape of the target with a ligand boundUse structures to explain selectivity and design analogues
Gene editing and knockdown (CRISPR, siRNA)Whether a response depends on a given targetA response that survives knockout points to a second target
Computational docking and molecular dynamicsPredicted binding poses and stabilityTreat predictions as hypotheses that assays must confirm

Pharmacogenomics links the bench to patients. Genetic variants in receptors, enzymes and transporters change how strongly a drug binds or how quickly it is metabolised, which is why molecular pharmacology essays increasingly include a paragraph on genetic variation. Keep this at the level of mechanism; individual prescribing decisions belong to clinical teams.

For the recombinant DNA techniques and cell culture behind these methods, see pharmaceutical biotechnology help.

Molecular pharmacology help at every level

Molecular pharmacology appears as a second-year unit in pharmacology and biomedical science degrees, as part of pharmacy and B.Pharm pharmacology papers, and as a full module at master's level. Tutors pitch the maths and the reading to your course.

LevelWhat you studyMatching help
BSc pharmacology and biomedical scienceReceptor theory, binding assays and signallingLive tutoring and homework help
MPharm, PharmD and B.PharmDrug–receptor interactions within pharmacology papersGeneral Pharmacology, Systemic Pharmacology and live tutoring
M.Pharm and MSc pharmacologyAdvanced receptor pharmacology and data analysisExperimental Pharmacology and assignment help
ResearchReceptor and signalling studiesDissertation help

Related: Pharmacology, Biochemistry, Cell Biology and Medicinal Chemistry II.

Where do students lose marks in molecular pharmacology?

Most lost marks come from mixing up binding and response terms.

Mark-loserWhat to do instead
Kd and EC50 treated as the sameKd is binding affinity; EC50 depends on efficacy and receptor reserve
Schild analysis without checking slopeA slope near 1 supports competitive antagonism
Partial agonists called weak antagonists onlyExplain they activate submaximally and can block full agonists
Pathways drawn without second messengersShow G protein, effector and messenger
Inverse agonists confused with antagonistsInverse agonists reduce constitutive activity
Data without replicatesReport means, variability and n

What molecular pharmacology assessments look like, and what markers want

Markers in molecular pharmacology look for correct models, correct parameters and honest reporting of fits. These are the features each format rewards.

AssessmentWhat markers look for
ExamsReceptor theory stated precisely, signalling pathways with named G proteins and messengers, and calculations with units
Data analysis assignmentsSpecific binding derived from total minus non-specific, the right model fitted, and Kd, Bmax, Ki or pA2 reported with error and n
Practical reportsOrgan bath or binding methods with concentrations, curves on a log scale, and a discussion of what the parameters mean
EssaysOne receptor or pathway explained from structure to cell response, using primary papers
PresentationsA drug's mechanism traced from binding to effect, with evidence for each step

Tools and software for molecular pharmacology

Molecular pharmacologists use these tools.

ToolWhat it is used for
GraphPad PrismBinding and dose–response analysis
IUPHAR/BPS Guide to PharmacologyReceptor data
PDB and PyMOLReceptor structures
Radioligand and fluorescence assaysBinding measurements
KEGG and ReactomeSignalling pathways

Country notes: studying molecular pharmacology around the world

Molecular pharmacology content follows the same receptor theory worldwide; the courses it sits in and the exams that test it differ.

CountryWhere molecular pharmacology is studiedExams and gradingWhat to watch for
United KingdomBSc Pharmacology, Biomedical Science, MPharmDegree classes; MPharm leads to the registration assessmentData-handling exams and practical reports using GraphPad Prism
United StatesPharmacology courses in PharmD programmes, graduate pharmacologyLetter grades and GPA; NAPLEX for pharmacistsMechanism-heavy exams and journal-club presentations
AustraliaPharmacy and biomedical science degreesHD, D, C, PCase-linked mechanism questions
CanadaPharmacology and pharmacy programmesLetter grades or percentagesSimilar to the US model, with lab-based data assignments
IndiaB.Pharm and M.Pharm (Pharmacy Council of India syllabus), MSc pharmacology, GPATUniversity exams and CGPA; GPAT rank for postgraduate entryReceptor classification and mechanism tables for long answers

Tutors follow your own module outline and schedule lessons in your time zone, including for students in Ireland, the Gulf, Europe, Africa and Asia. The content is educational and does not cover prescribing or treatment advice.

How is molecular pharmacology taught and assessed in the UK, US, Australia, Europe and the Gulf?

Receptor theory is the same worldwide, but the degrees that teach it and the way it is examined vary. This table adds Ireland, New Zealand, the EU, Southeast Asia and the Gulf to the country notes above.

RegionWhere molecular pharmacology is taughtAssessment and grading
UK and IrelandBSc pharmacology and biomedical science, MPharm, and MSc pharmacology; Irish pharmacy and pharmacology degreesData-handling exams, practical reports and essays; UK degrees classed First to Third, with similar honours bands in Ireland
US and CanadaGraduate pharmacology programmes, PharmD pharmacology sequences and undergraduate pharmacology or neuroscience majorsProblem sets, exams and journal clubs; letter grades and GPA
Australia and New ZealandPharmacology majors in science and biomedical degrees, and pharmacy degreesPractical reports and exams; HD to P in Australia, letter grades in New Zealand
Europe (EU)Molecular pharmacology courses in pharmacy, pharmaceutical sciences and drug discovery Master's programmes, some taught as lab-based group projectsWritten and oral exams and group reports; ECTS credits (60 per year) with national grading scales
Singapore and MalaysiaPharmacy and pharmacology degrees and biomedical science programmesContinuous assessment and final exams; grade point averages
GCC (UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain)PharmD and BPharm programmes and biomedical science degrees, often taught in EnglishExams, case-based assignments and lab reports; letter grades and GPA
IndiaB.Pharm, M.Pharm pharmacology and MSc programmesUniversity exams with long-answer mechanism questions; CGPA

Whatever the system, examiners reward the same skills: naming the target and its family, giving the binding or signalling mechanism step by step, and interpreting data with the right equation and units.

How much does molecular pharmacology help cost?

A few occupancy questions take far less time than a full binding analysis with figures, so the price depends on the task and the deadline. You are shown a fixed quote (for written guidance) or an hourly rate (for live lessons) up front, and nothing ties you to a contract or a minimum number of sessions. Refunds follow our refund policy.

Get a free molecular pharmacology quote.

Molecular pharmacology students are matched with tutors who hold a master's or PhD in pharmacology, molecular pharmacology or a related biomedical science and have run binding or functional assays and analysed the data in GraphPad Prism or similar software. Sessions start from your own data, figure or essay question, and the tutor works a similar dataset or mechanism with you so that your submitted report and conclusions remain your own. All teaching is educational only and does not cover prescribing or treatment of any patient.

If your question moves on toThe related subject
How drug action translates into effects and safety in patientsClinical pharmacology help
The chemistry of drug molecules, structure–activity relationships and synthesisPharmaceutical chemistry help
Recombinant proteins, biologics and the cell systems used in assaysPharmaceutical biotechnology help

Typical requests. A saturation curve that will not fit; a competition assay where the Ki looks wrong because the radioligand Kd was entered in the wrong units; a Schild plot with a slope far from 1; an essay on biased agonism or allosteric modulation; and revision of receptor families and signalling pathways before an exam.

Stuck on a Molecular Pharmacology question?

Send it to a Molecular Pharmacology tutor for step-by-step working. The quote is free.

What you get

Every Molecular Pharmacology order includes

  • Written from scratch to your exact brief
  • Fully referenced in your required citation style
  • Plagiarism-checked before delivery
  • Free revisions until you are satisfied
  • 100% confidential — your privacy protected
3 hours
Fastest delivery
Free, unlimited
Revision policy

Simple process

How your Molecular Pharmacology help works

01

Describe your Molecular Pharmacology task

Tell us your assignment brief, word count, deadline, and academic level. The more detail, the better the match.

02

Matched to a specialist

We pair you with a Molecular Pharmacology expert whose background aligns with your specific topic and university requirements.

03

Delivered, checked, revised

Your work arrives before the deadline, plagiarism-checked. Free revisions until it meets your exact requirements.

Takes about two minutes. The quote is free.

Molecular Pharmacology and related specialists

Who handles your Molecular Pharmacology work

Every expert is degree-verified and quality-tested before joining.

  • Sumit Kumar

    S. Kumar

    VERIFIED
    Pharmacology & Pharmaceutical Sciences Expert

    I specialize in Pharmacology and Pharmaceutical Sciences, with a focus on Clinical Pharmacology, Drug Discovery and Development, Pharmacokinetics, Pharmacodynamics, and Toxicology. I help students understand complex pharmaceutical concepts through clear explanations and…

    • Drug Mechanism of Action Analysis
    • Pharmacological Data Interpretation
    • Pharmacokinetic Calculations
    • Pharmacodynamic Analysis
    15$/hr
    Rate
  • Rahul Sani

    R. Sani

    VERIFIED
    Pharmacology Expert & Tutor

    Understanding how medicines work in the human body is essential for safe and effective healthcare. As a Pharmacology Tutor, I focus on helping students build a strong understanding of Clinical Pharmacology, Pharmacokinetics, Pharmacodynamics, Drug Mechanisms of Action, and…

    • Pharmacological Concept Analysis
    • Drug Mechanism Interpretation
    • Pharmacokinetic Calculations
    • Pharmacodynamic Analysis
    15$/hr
    Rate
  • Divyanshi  sharma

    D. sharma

    VERIFIED
    Pharmacy & Pharmacology Expert

    I am passionate about making pharmacy and pharmacology easier to understand by connecting scientific concepts with practical healthcare applications. My teaching focuses on general pharmacology, clinical pharmacology, pharmacokinetics, pharmacodynamics, drug mechanisms of…

    • Pharmacological Analysis
    • Pharmacokinetic Calculations
    • Pharmacodynamic Analysis
    • Drug Mechanism Interpretation
    13$/hr
    Rate
  • Asad Bajwa

    A. Bajwa

    VERIFIED
    Medical Sciences Tutor & Physician

    My teaching goes beyond explaining medical concepts. I focus on building a personalized learning strategy that works for you. This includes creating realistic daily and weekly study schedules, identifying weak areas, setting achievable targets, and tracking progress through…

    • USMLE prep guidance and Topic based lectures
    • Basic medical sciences lecures and guidance
    • Exam prep guidance.
    • Medical Subject Knowledge
    31 min
    Reply
    From $15/hr
    Rate

Student reviews

What students say about Molecular Pharmacology help

Used FLN Tutors? Be one of the first to share how it went, in writing or in a short video.

Molecular Pharmacology tutoring: frequently asked questions

Can you help with molecular pharmacology?

Yes. A tutor explains receptor theory and cell signalling, works through binding, Schild and concentration–response calculations with you and gives feedback on essays and data reports. You then analyse the next dataset yourself and the tutor checks it, all within your institution's rules on independent work.

What is molecular pharmacology?

Molecular pharmacology studies how drugs interact with their molecular targets, mainly receptors, ion channels, enzymes and transporters, and how that interaction changes signalling inside cells. It explains potency, efficacy and selectivity in terms of binding and coupling, and links pharmacology to biochemistry, cell biology and structural biology.

What are the four main receptor families?

The four families are G protein-coupled receptors, such as β-adrenoceptors; ligand-gated ion channels, such as the nicotinic receptor; kinase-linked receptors, such as the insulin receptor; and nuclear receptors, such as the glucocorticoid receptor. They act on very different time scales, from milliseconds for ion channels to hours for nuclear receptors.

What is Kd?

Kd is the equilibrium dissociation constant for a ligand and its receptor: the concentration at which half the receptors are occupied at equilibrium. A lower Kd means higher affinity. It is measured by saturation binding and is a property of the drug–receptor pair, so it should not be confused with EC50, which depends on the tissue.

What is Bmax?

Bmax is the total density of binding sites in a preparation, reached when the ligand saturates every receptor. It is usually expressed in fmol per mg of protein or as sites per cell. Changes in Bmax show receptor up- or downregulation, for example after long-term agonist or antagonist exposure.

How is fractional occupancy calculated?

For simple one-site binding at equilibrium, fractional occupancy = [L] ÷ ([L] + Kd), where [L] is the free ligand concentration. At [L] = Kd, occupancy is 50%; at nine times Kd, it is 90%. Multiplying occupancy by Bmax gives the specific binding expected at that concentration.

What is a partial agonist?

A partial agonist binds the receptor but has lower intrinsic efficacy than a full agonist, so it cannot produce the maximum response even when every receptor is occupied. Because it occupies receptors, it can reduce the response to a full agonist given at the same time. Buprenorphine at μ-opioid receptors is the usual teaching example.

What is an inverse agonist?

An inverse agonist binds a receptor that has some activity even without an agonist, called constitutive activity, and reduces that activity below baseline. A neutral antagonist, by contrast, has no effect on its own and simply blocks agonists. Several drugs once classed as antagonists, including some antihistamines, behave as inverse agonists.

What is a Schild plot?

A Schild plot graphs log(dose ratio − 1) against log antagonist concentration, where the dose ratio is the agonist EC50 with antagonist divided by the EC50 without. For simple competitive antagonism the points fall on a straight line with slope 1, and the x-intercept gives the pA2, the antagonist's affinity estimate.

What is pA2?

pA2 is the negative logarithm of the antagonist concentration that makes a dose ratio of 2, meaning twice as much agonist is needed for the same response. When the Schild slope is 1, pA2 equals the pKB, a direct measure of the antagonist's affinity that is independent of the agonist used.

What are spare receptors?

Spare receptors, or a receptor reserve, exist when a full agonist produces its maximum response while occupying only a fraction of the receptors. The EC50 then lies below the Kd. Receptor reserve varies between tissues, which is why the same agonist can be full in one tissue and partial in another.

How much does molecular pharmacology help cost?

The price depends on the task and the deadline: a few occupancy questions take far less time than a full binding analysis with figures. Send your brief and deadline for a free quote, which you see before anything is booked; live lessons use the tutor's hourly rate, and there is no contract or minimum number of sessions.

How is molecular pharmacology used in drug discovery?

Molecular pharmacology identifies the target a new drug should act on, measures how strongly candidate molecules bind and whether they activate or block it, and explains selectivity using structures and mutagenesis. These binding and functional data guide chemists as they modify molecules, long before any testing in animals or people begins.

What is biased agonism?

Biased agonism, or functional selectivity, is when a ligand stabilises receptor shapes that favour one signalling pathway over another, for example G protein signalling over β-arrestin recruitment at the same receptor. It is studied as a way to keep a drug's useful effect while reducing an unwanted one, and is a common essay topic.

Is molecular pharmacology hard?

Molecular pharmacology is detailed and mathematical in places, but the equations are few and repeat across topics. Students find it easier once they separate binding terms (Kd, Bmax, Ki) from response terms (EC50, Emax, efficacy) and practise fitting real data. Drawing each pathway from receptor to response also helps.

Which molecular pharmacology textbook do tutors use?

Tutors work from the books your course recommends, such as Rang and Dale's Pharmacology, Kenakin's A Pharmacology Primer, Goodman and Gilman's The Pharmacological Basis of Therapeutics and Golan's Principles of Pharmacology. The IUPHAR/BPS Guide to Pharmacology database is used for receptor nomenclature and affinity values.

Can I get molecular pharmacology help the same day?

Often, yes. Short occupancy, Ki or Schild questions can usually be explained the same day, depending on which tutors are available. A full data analysis with curve fitting or an essay takes longer, so send your data files, the brief and the deadline as early as possible.

What forces hold a drug to its receptor?

Most drugs bind reversibly through several weak forces acting together: ionic attractions, hydrogen bonds, van der Waals contacts and the hydrophobic effect. The fit of the drug's shape to the binding pocket decides how many of these can form. A few drugs form covalent bonds instead, which makes their binding effectively irreversible.

Is it allowed to get molecular pharmacology help?

Yes, when it supports your learning. Tutoring, worked examples on similar datasets and feedback on a draft are normal study support. The analysis and report you submit must be your own under your university's academic integrity rules. Our academic integrity policy explains how data-analysis help is kept within them.

Is my molecular pharmacology work kept confidential?

Yes. Binding data, organ bath results, drafts and personal details are used only to support your learning and are not shared with your university, supervisor or anyone else. Unpublished research data stays private. The privacy policy explains how files are stored and deleted.

Question not answered here?

Not sure which service you need?

Tell us your assignment brief and deadline — we'll match you with the right expert and service instantly.

Money-Back Guarantee

Full refund if we miss the agreed deadline, can't find a suitable expert, or major errors can't be fixed by revision.

Learn more →

100% Confidential

Your identity, order details and institution are never shared with any third party.

Learn more →

Deadline-Backed Delivery

Every order has an agreed deadline. If we don't deliver by it, you can claim a full refund.

Learn more →

Get started today

Ready to get expert help?

Tell us what you need and get matched with a tutor who teaches your subject. Delivered on time, every time.

See how it works
Instant quoteNo account needed to get a priceFree revisions100% confidential